Live from the NIH registry
Studies recruiting near Winter Haven right now
Top 25 of 162 recruiting studies, sorted by proximity — each links to its official registry page
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Lakeland, Florida (15.3 mi)
· Sponsor: GlaxoSmithKline
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Diabetic Retinopathy
Phase 2, Phase 3
Interventional 576 participants sought
Florida Retina Consultants - Lakeland /ID# 275012 — Lakeland, Florida (15.3 mi)
· Sponsor: AbbVie
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
Clinical Research of Cent FL — Winter Haven, Florida (2.1 mi)
· Sponsor: Novo Nordisk A/S
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
Radiology and Imaging Specialists — Lakeland, Florida (15.3 mi)
· Sponsor: Penumbra Inc.
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Winter Haven Hospital — Winter Haven, Florida (2.1 mi)
· Sponsor: Amgen
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Winter Haven Hospital — Winter Haven, Florida (2.1 mi)
· Sponsor: Novo Nordisk A/S
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Florida Retina Consultants — Lakeland, Florida (15.3 mi)
· Sponsor: EyeBiotech Ltd.
TNF-α Treatment of Blast-Induced Tinnitus
Tinnitus, Noise Induced
Phase 2
Interventional 88 participants sought
Advent Health — Celebration, Florida (24.0 mi)
· Sponsor: Wayne State University
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
AdventHealth Celebration — Celebration, Florida (24.0 mi)
· Sponsor: SWOG Cancer Research Network
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Kissimmee — Kissimmee, Florida (26.7 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Nephritis, Lupus, Lupus Erythematosus, Systemic
Phase 3
Interventional 300 participants sought
Alloy Clinical Research LLC — Kissimmee, Florida (26.7 mi)
· Sponsor: Viatris Innovation GmbH
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma
Phase 1, Phase 2
Interventional 768 participants sought
Helios CR Inc — Lakeland, Florida (15.3 mi)
· Sponsor: Boehringer Ingelheim
SMP-3124LP in Adults With Advanced Solid Tumors
Solid Tumor
Phase 1, Phase 2
Interventional 120 participants sought
Advent Health — Celebration, Florida (24.0 mi)
· Sponsor: Sumitomo Pharma America, Inc.
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1
Interventional 525 participants sought
Adventhealth — Celebration, Florida (24.0 mi)
· Sponsor: BeOne Medicines
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
The Oncology Institute — Lakeland, Florida (15.3 mi)
· Sponsor: Jazz Pharmaceuticals
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Kissimmee, Florida (26.7 mi)
· Sponsor: GlaxoSmithKline
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
Interventional 751 participants sought
Clinical Research of Osceola - Site Number: 8400013 — Kissimmee, Florida (26.7 mi)
· Sponsor: Sanofi
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Peripheral Arterial Disease
N/A
Interventional 159 participants sought
Radiology and Imaging Specialists of Lakeland — Lakeland, Florida (15.3 mi)
· Sponsor: Nipro Vascular Innovations Americas, Inc
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 600 participants sought
Clinical Research of Osceola, LLC — Kissimmee, Florida (26.7 mi)
· Sponsor: Hoffmann-La Roche
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Psoriatic Arthritis, Overweight or Obesity
Phase 4
Interventional 200 participants sought
Vida Clinical Research — Kissimmee, Florida (26.7 mi)
· Sponsor: Eli Lilly and Company
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Winter Haven Hospital — Winter Haven, Florida (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Hypertension, Hypertension, Systolic
N/A
Interventional 316 participants sought
Cardiovascular Research Solutions (MyCardiologist) — Celebration, Florida (24.0 mi)
· Sponsor: Orchestra BioMed, Inc
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
Psoriatic Arthritis
Phase 3
Interventional 63 participants sought
Healing Rheumatology — Plant City, Florida (25.2 mi)
· Sponsor: University of Pennsylvania
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Liver Neoplasms, Primary Liver Cancer
N/A
Observational 5,000 participants sought
AdventHealth Celebration — Celebration, Florida (24.0 mi)
· Sponsor: HistoSonics, Inc.
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain Neuropathy
Phase 2
Interventional 240 participants sought
Central Recruiting Site — Lakeland, Florida (15.3 mi)
· Sponsor: Dogwood Therapeutics Inc.